Filing Details

Accession Number:
0001127602-17-022048
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-22 17:32:59
Reporting Period:
2017-06-21
Filing Date:
2017-06-22
Accepted Time:
2017-06-22 17:32:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711404 Cooper Companies Inc COO Ophthalmic Goods (3851) 942657368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368867 G Daniel Mcbride The Cooper Companies, Inc.
6140 Stoneridge Mall Road, Suite 590
Pleasanton CA 94588
Evp, Coo & Pres-Coopervision No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-21 6,000 $13.10 34,395 No 4 M Direct
Common Stock Disposition 2017-06-21 6,000 $244.23 28,395 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2017-06-21 6,000 $0.00 6,000 $13.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,120 Indirect 401(k) Plan
Footnotes
  1. Sales price represents an average sales price between $244.13 and $244.47.
  2. 12/11/08 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/09; 1/5 shall vest on 12/11/10/; 1/5 shall vest on 12/11/11; 1/5 shall vest on 12/11/12; and 1/5 shall vest on 12/11/13.